Hope for spinal muscular atrophy
Nature Biotechnology
2010년3월1일
A new therapeutic approach for spinal muscular atrophy is demonstrated in a mouse model in this week's Nature Biotechnology. Although further research is needed to determine whether the approach will be viable in human infants, the results are considered promising by spinal muscular atrophy experts.
Spinal muscular atrophy, a genetic disorder of infants, is caused by reduced function of the 'survival motor neuron' protein in nerve cells and leads to progressive muscle weakness and early death. Brian Kaspar and colleagues previously showed that a gene can be delivered to spinal motor nerve cells in newborn mice simply by injecting a specific engineered virus carrying the gene into the blood. Now, working with spinal muscular atrophy researcher Arthur Burghes, the Kaspar team has used the engineered virus to deliver the survival motor neuron gene to a strain of mouse that is used as a model of spinal muscular atrophy. Without treatment, these mice die within about 15 days, and previous experimental therapies had increased their survival to only about 45 days. In contrast, the new gene therapy outlined in this paper kept the mice alive for more than 250 days and substantially improved their muscle function.
As a first step in evaluating whether this approach could be translated to human infants, the authors injected the engineered virus carrying a fluorescent 'reporter' gene ― which is easy to track ― into a newborn cynomolgus monkey. They found that the fluorescent gene was successfully delivered to spinal motor nerve cells, suggesting that the therapy could work in non-human primates and, possibly, in humans.
doi: 10.1038/nbt.1610
리서치 하이라이트
-
7월7일
Public health: Tackling adolescent stressNature
-
6월23일
Scientific community: Women credited less than men in scientific paper authorshipNature
-
5월12일
Geoscience: Monitoring earthquakes at the speed of lightNature
-
5월4일
Microbiology: Bacteriophage therapy helps treat multi-drug resistant infection in an immunocompromised patientNature Communications
-
4월27일
Planetary science: Building blocks of DNA detected in meteoritesNature Communications
-
4월8일
Health: Psilocybin use associated with lower risk of opioid addictionScientific Reports